RESEARCH DESIGN AND METHODS Study subjects A total of 116 patients with type 2 diabe-tes were recruited from 24 sites through-out the U.S. Males, or females who weresurgically sterile or postmenopausal, aged18–65 years were eligible for enrollment.Patients were to be treated with diet and aregimen of sulfonylurea or metformin(alone or in combination) that was stablefor at least the prior 6 months. The entryoral antidiabetic agent regimen was con-tinued throughout the study. Planned en-try HbA 1cwas between 8.0 and 11.0%. Actual enrolled HbA1cranges are given in Table 1. The target BMI at enrollment was 27–40 kg/m2, inclusive. The following institutional review boards approved this